Name	MOA	Target	Phase
ABC-294640	sphingosine kinase inhibitor	SPHK2	Phase 2
acetazolamide	carbonic anhydrase inhibitor	AQP1, CA1, CA12, CA14, CA2, CA3, CA4, CA7	Launched
acetohydroxamic-acid	urease inhibitor	MMP12	Launched
acetyl-farnesyl-cysteine	methyltransferase inhibitor	PPARG	Launched
acitretin	retinoid receptor agonist	RARA, RARB, RARG, RBP1, RXRA, RXRB, RXRG, STAT3	Launched
AEE788	EGFR inhibitor, VEGFR inhibitor	EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR	Phase 1/Phase 2
AG-555	tyrosine kinase inhibitor	CDK2	Preclinical
agmatine	nitric oxide synthase inhibitor	ADRA2C, ASIC3, CACNA1B, CHRNA1, GRIN1, KCNJ1, NISCH	Phase 3
AK-7	SIRT inhibitor	SIRT2	Preclinical
alantolactone	apoptosis stimulant, STAT inhibitor	STAT3	Preclinical
alvocidib	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, EGFR, PYGM	Phase 2
amiloride	sodium channel blocker	AOC1, ASIC1, ASIC2, ASIC3, PKD2, PKD2L1, PLAU, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC9A1, TRPC7, TRPV2	Launched
aminopurvalanol-a	CDK inhibitor, tyrosine kinase inhibitor	CDK1, CDK2, CDK5	Preclinical
amitriptyline	norepinephrine inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR6, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1, SLC6A2, SLC6A4	Launched
amlexanox	histamine receptor modulator	FGF1, IL3, PDE4A, PDE4B, PDE4C, PDE4D, S100A12, S100A13	Launched
APcK-110	KIT inhibitor	KIT, STAT3	Preclinical
API-001	sigma receptor antagonist	SIGMAR1	Phase 2
apigenin	casein kinase inhibitor, cell proliferation inhibitor	AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1B1, HSD17B1	Preclinical
apratastat	matrix metalloprotease inhibitor, tumor necrosis factor production inhibitor	ADAM17, MMP1, MMP13, MMP9	Phase 2
aspirin	cyclooxygenase inhibitor	AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PTGS1, PTGS2, RPS6KA3, TP53	Launched
AT-7519	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CDK6, CDK9	Phase 2
atiprimod	JAK inhibitor, STAT inhibitor	JAK2, STAT3	Phase 2
AZD4547	FGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, IGF1R, KDR	Phase 2/Phase 3
AZD8931	EGFR inhibitor	EGFR, ERBB2, ERBB3	Phase 2
BADGE	PPAR receptor antagonist	PPARG	Preclinical
balaglitazone	insulin sensitizer, PPAR receptor partial agonist	PPARG	Phase 3
balsalazide	cyclooxygenase inhibitor	ALOX5, PPARG, PTGS1, PTGS2	Launched
bardoxolone	nuclear factor erythroid derived, like (NRF2) activator	NOS2, PPARG	Phase 1
bardoxolone-methyl	nuclear factor erythroid derived, like (NRF2) activator	PPARG, STAT3	Phase 3
batimastat	matrix metalloprotease inhibitor	ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8	Phase 3
BD-1047	adrenergic receptor antagonist	SIGMAR1	Preclinical
BD-1063	sigma receptor antagonist	SIGMAR1	Preclinical
bezafibrate	PPAR receptor agonist	PPARA, PPARD, PPARG	Launched
bicyclol	NFkB pathway inhibitor	HSPA1A, HSPB1	Launched
bindarit	NFkB pathway inhibitor	CCL2, CCL7, CCL8	Phase 2
bisindolylmaleimide-IX	PKC inhibitor	AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1	Preclinical
BMS-265246	CDK inhibitor	CDK1, CDK2	Preclinical
BMS-387032	CDK inhibitor, cell cycle inhibitor, MCL1 inhibitor	CDK2, CDK7, CDK9	Phase 1
BMS-536924	IGF-1 inhibitor	AKT1, CCNE1, CDK2, CYP3A4, ERBB2, IGF1R, KDR, LCK, MAPK1, MET, PDGFRA, PDGFRB	Preclinical
bosutinib	Abl kinase inhibitor, Bcr-Abl kinase inhibitor, SRC inhibitor	ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK	Launched
BQU57	Ras GTPase inhibitor	RALA, RALB	Preclinical
brefeldin-A	protein synthesis inhibitor	ARF1, CYTH2	Preclinical
brinzolamide	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA5A, CA7	Launched
brivanib-alaninate	FGFR inhibitor, VEGFR inhibitor	FGFR3	Phase 3
bumetanide	solute carrier family member inhibitor	CFTR, GPR35, SLC12A1, SLC12A2, SLC12A4, SLC12A5	Launched
BX-795	IKK inhibitor	CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1	Preclinical
BX-912	pyruvate dehydrogenase kinase inhibitor	CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1	Preclinical
camostat-mesilate	protease inhibitor	PRSS1	Launched
cardionogen-1	WNT signaling inhibitor	CTNNB1	Preclinical
carzenide		CA1, CA12, CA14, CA2, CA6, CA9	Preclinical
CCT-031374	WNT signaling inhibitor	CTNNB1	Preclinical
celecoxib	cyclooxygenase inhibitor	CA12, PDPK1, PTGS2	Launched
ceritinib	ALK tyrosine kinase receptor inhibitor	ALK, FLT3, IGF1R, INSR, TSSK1B	Launched
cetilistat	triacylglycerol lipase inhibitor	PNLIP	Phase 3
CFTRinh-172	chloride channel blocker	CFTR	Preclinical
CGP-60474	CDK inhibitor	CDK1, CDK2	Preclinical
CH-5183284	fibroblast growth factor inhibitor	FGFR1, FGFR2, FGFR3	Phase 2
chlorthalidone	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA7, SLC12A1	Launched
cholic-acid	bile acid	ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B	Launched
ciglitazone	PPAR receptor agonist	PPARG	Phase 2
cipemastat	metalloproteinase inhibitor	ADAM17, MMP1, MMP13, MMP2, MMP3, MMP8, MMP9	Phase 3
CK-636	actin related protein inhibitor	ACTR2, ACTR3, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5	Preclinical
clobetasol-propionate	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Launched
clocortolone-pivalate	steroid	NR3C1, PLA2G1B	Launched
coenzyme-I		AASS, ACADS, ADH1A, ADH1B, ADH1C, ADH4, ADH5, ADH7, AKR1B1, AKR1C1, AKR1C2, AKR1C3, AKR1C4, ALDH1A1, ALDH1A2, ALDH1A3, ALDH1B1, ALDH2, ALDH3A1, ALDH3A2, ALDH3B1, ALDH3B2, ALDH4A1, ALDH5A1, ALDH6A1, ALDH7A1, ALDH9A1, AMT, BDH1, BLVRA, BLVRB, CDO1, CYB5R3, CYP17A1, CYP4A11, DHCR7, DHFR, DLAT, DLD, EHHADH, GAPDH, GAPDHS, GLUD1, GLUD2, GPD1, GSR, H6PD, HADH, HADHA, HIBADH, HMGCR, HMOX1, HMOX2, HPGD, HSD11B1, HSD11B2, HSD17B1, HSD17B10, HSD17B2, HSD17B3, HSD17B4, HSD17B7, HSD17B8, HSD3B1, HSD3B2, IDH3A, IDH3B, IDH3G, IMPDH1, IMPDH2, LDHA, LDHAL6A, LDHAL6B, LDHB, LDHC, MDH1, MDH2, ME1, ME2, ME3, MSMO1, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MTHFD1, MTHFD2, NDUFA1, NDUFA10, NDUFA11, NDUFA12, NDUFA13, NDUFA2, NDUFA3, NDUFA4, NDUFA4L2, NDUFA5, NDUFA6, NDUFA7, NDUFA8, NDUFA9, NDUFAB1, NDUFB1, NDUFB10, NDUFB2, NDUFB3, NDUFB4, NDUFB5, NDUFB6, NDUFB7, NDUFB8, NDUFB9, NDUFC1, NDUFC2, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS5, NDUFS6, NDUFS7, NDUFS8, NDUFV1, NDUFV2, NDUFV3, NNT, NQO2, NSDHL, OGDH, PDHA1, PDHA2, PDHB, PHGDH, PYCR1, PYCR2, QDPR, RDH5, SORD, TSTA3, TYR, UGDH	Phase 2
CP-471474	matrix metalloprotease inhibitor	MMP1, MMP13, MMP2, MMP3, MMP9	Preclinical
CPA-inhibitor	carboxypeptidase inhibitor	CPA1, CPA2	Preclinical
cryptotanshinone	acetylcholinesterase inhibitor, STAT inhibitor	STAT3	Preclinical
CTS-1027	metalloproteinase inhibitor	MMP1, MMP13, MMP2, MMP3, MMP9	Phase 2
curcumin	cyclooxygenase inhibitor, histone acetyltransferase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor	APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CHRM3, CYP3A4, DNMT3B, EP300, MMP13, MMP9, NOS2, PTGS1, PTGS2, XDH	Launched
cutamesine	sigma receptor agonist	SIGMAR1	Phase 2
dabrafenib	RAF inhibitor	BRAF, LIMK1, NEK11, RAF1, SIK1	Launched
dalbavancin	bacterial cell wall synthesis inhibitor	PNLIP	Launched
danazol	estrogen receptor antagonist, progesterone receptor agonist	AR, CCL2, ESR1, GNRHR, GNRHR2, PGR	Launched
darglitazone	PPAR receptor antagonist	PPARG	Phase 2
desonide	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Launched
desoximetasone	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Launched
dexfosfoserine	membrane integrity inhibitor	CFTR, GRM4, GRM6, GRM7, GRM8, KCNC4, PDPK1, PIM1, PRKACA, PRKCQ, PYGL, PYGM, REG1A, RHO, SERPINB3, SMAD2, TAOK2	Preclinical
dextromethorphan	glutamate receptor antagonist, sigma receptor agonist	CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SIGMAR1, SLC6A2, SLC6A4	Launched
diclofenac	cyclooxygenase inhibitor	AKR1C3, ALOX5, ASIC1, ASIC3, KCNQ2, KCNQ3, PLA2G2A, PPARG, PTGS1, PTGS2, SCN4A	Launched
diclofenamide	carbonic anhydrase inhibitor	CA1, CA12, CA2, CA4, CA7	Launched
dimemorfan	sigma receptor agonist	SIGMAR1	Launched
diminazene-aceturate	angiotensin converting enzyme activator	AOC1, PRDX5, PRSS1	Phase 3
dinaciclib	CDK inhibitor	CDK1, CDK2, CDK5, CDK9	Phase 3
ditolylguanidine	sigma receptor agonist	GRIN1, GRIN2A, GRIN2B, SIGMAR1	Preclinical
dorzolamide	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA7	Launched
dovitinib	EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB	Phase 3
ebselen	cyclooxygenase inhibitor, glutathione peroxidase agonist, H+/K+-ATPase inhibitor, nitric oxide synthase inhibitor	ALB	Phase 2/Phase 3
edaglitazone	PPAR receptor agonist	PPARG	Phase 2
efatutazone	PPAR receptor agonist	PPARG	Phase 2
EHop-016	Ras GTPase inhibitor	RAC1, RAC3	Preclinical
EIPA	sodium/hydrogen exchanger inhibitor, transient receptor potential polycystic inhibitor	ADRA2A, ASIC1, PKD2L1	Preclinical
elafibranor	PPAR receptor agonist	PPARA, PPARD, PPARG	Phase 3
ellagic-acid	glutathione transferase inhibitor, non-nucleoside reverse transcriptase inhibitor	CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, GSK3B, PRKACA, PRKCA, PRKCB, SQLE, SYK	Phase 2
epigallocatechin-gallate-(-)	bacterial DNA gyrase inhibitor	ELANE, EP300, FASN, KAT2B, MMP14, MMP2	Phase 2/Phase 3
eprodisate	amyloid protein inhibitor, antiamyloidogenic agent	SAA1	Phase 3
erdafitinib	FGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4	Launched
erythromycin-estolate	bacterial 50S ribosomal subunit inhibitor	ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1	Launched
erythromycin-ethylsuccinate	cytochrome P450 inhibitor, protein synthesis inhibitor	ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1	Launched
ethoxzolamide	carbonic anhydrase inhibitor	CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9	Launched
etomoxir	carnitine palmitoyltransferase inhibitor	CPT1A	Phase 2
EX-527	SIRT inhibitor	SIRT1	Phase 2
FH-535	PPAR receptor antagonist, WNT signaling inhibitor	PPARD, PPARG	Preclinical
flumethasone	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Launched
flupirtine	glutamate receptor antagonist	ADRA2A, KCNQ1, KCNQ2	Launched
freselestat	elastase inhibitor	CELA1, ELANE	Preclinical
gabexate	serine protease inhibitor	PRSS1, TPSAB1	Launched
gallic-acid	beta amyloid protein neurotoxicity inhibitor, PPAR receptor agonist	CA1, CA12, CA14, CA2, CA4, CA6, CA9, SELP	Preclinical
genistein	tyrosine kinase inhibitor	CFTR, ESR1, ESR2, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5	Phase 2/Phase 3
glafenine	DeltaF508-CFTR Correctors	CFTR	Withdrawn
GSK1838705A	insulin growth factor receptor inhibitor	ALK, IGF1R, INSR, RPS6KA1	Preclinical
GSK1904529A	IGF-1 inhibitor, insulin growth factor receptor inhibitor, insulin receptor ligand	IGF1R, INSR	Preclinical
GW-1929	PPAR receptor agonist	PPARG	Preclinical
GW-9662	PPAR receptor antagonist	NCOA2, PPARG, RXRA	Preclinical
halobetasol-propionate	glucocorticoid receptor agonist	NR3C1, PLA2G1B	Launched
hydrochlorothiazide	thiazide diuretic	CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A3	Launched
hydroflumethiazide	sodium/potassium/chloride transporter inhibitor	ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A1, SLC12A3	Launched
ibuprofen-(S)	cyclooxygenase inhibitor	ASIC1, PTGS1, PTGS2, SLC5A8	Launched
ICG-001	beta-catenin inhibitor	CTNNB1	Preclinical
icosapent	platelet aggregation inhibitor	ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, PTGS1, PTGS2, SLC8A1, TRPV1	Launched
iCRT-14	beta catenin inhibitor, WNT signaling inhibitor	CTNNB1, TCF4	Preclinical
igmesine	sigma receptor agonist	SIGMAR1	Phase 2
ilomastat	matrix metalloprotease inhibitor	ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9	Phase 3
indeglitazar	PPAR receptor agonist	NCOA1, PPARA, PPARD, PPARG	Phase 2
indirubin-3-monoxime	CDK inhibitor, glycogen synthase kinase inhibitor	CDK1, CDK2, CDK5, CDK5R1, GSK3B	Preclinical
indisulam	CDK inhibitor	CA1, CA12, CA14, CA2, CA6, CA7, CA9	Phase 2
indomethacin	cyclooxygenase inhibitor	GLO1, PLA2G2A, PPARA, PPARG, PTGDR2, PTGR2, PTGS1, PTGS2, SLC46A1	Launched
ivacaftor	CFTR channel potentiator	CFTR	Launched
JNJ-7706621	CDK inhibitor	AURKA, AURKB, CDK1, CDK2	Preclinical
K145	sphingosine kinase inhibitor	SPHK2	Preclinical
L-aspartic-acid	metallic radical formation stimulant	ACY1, ACY3, ADSS, ADSSL1, ASNS, ASPA, ASPH, ASRGL1, ASS1, CAD, DARS, DARS2, GOT1, GOT2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, LYZ, PAICS, RNASE1, SLC1A1, SLC25A12, SLC25A13	Launched
L-mimosine	dopamine beta hydroxylase inhibitor, eukaryotic translation initiation factor inhibitor	DBH, EIF5A	Preclinical
L-365260	CCK receptor antagonist	CCKAR, CCKBR, KCNQ1	Phase 2
L-693403	sigma receptor agonist, sigma receptor antagonist	DRD2, SIGMAR1	Preclinical
levosulpiride	dopamine receptor antagonist	CA1, CA12, CA7, DRD2, DRD3	Launched
linsitinib	IGF-1 inhibitor	IGF1R, INSR, INSRR	Phase 3
lumacaftor	CFTR channel agonist	CFTR	Launched
mafenide	carbonic anhydrase inhibitor	CA12, CA14, CA2, CA4, CA6, CA9	Launched
magnolol	PPAR receptor agonist	GABRA1, PPARG	Preclinical
marimastat	matrix metalloprotease inhibitor	MMP1, MMP10, MMP11, MMP12, MMP13, MMP14, MMP15, MMP16, MMP17, MMP19, MMP2, MMP20, MMP21, MMP23A, MMP24, MMP25, MMP26, MMP27, MMP28, MMP3, MMP7, MMP8, MMP9	Phase 3
masitinib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, SRC inhibitor	FGFR3, KIT, PDGFRA, PDGFRB	Launched
mefenamic-acid	cyclooxygenase inhibitor	KCNQ1, PTGS1, PTGS2, TRPM3	Launched
meisoindigo	STAT inhibitor	STAT3	Phase 3
mepacrine	cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator	PLA2G1B	Launched
mesalazine	cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist	ALOX5, CHUK, IKBKB, MPO, PPARG, PTGS1, PTGS2	Launched
methazolamide	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA7	Launched
mifobate	PPAR receptor antagonist	PPARG	Phase 2
miltefosine	membrane integrity inhibitor	PLA2G1B	Launched
mimosine	DNA replication inhibitor	CCL2, SHMT1, SHMT2, TYR	Preclinical
MK-2461	FGFR inhibitor, VEGFR inhibitor	FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB	Phase 1/Phase 2
ML277	potassium channel activator	KCNQ1	Preclinical
nafamostat	serine protease inhibitor	ASIC1, ASIC2, ASIC3, C1R, PRSS1, TPSAB1, TRPM7	Launched
naltrexone	opioid receptor antagonist	OPRD1, OPRK1, OPRM1, SIGMAR1	Launched
napabucasin	STAT inhibitor	STAT3	Phase 3
NE-100	sigma receptor antagonist	SIGMAR1	Phase 2
niclosamide	DNA replication inhibitor, STAT inhibitor	STAT3	Launched
niflumic-acid	cyclooxygenase inhibitor	ANO1, CLCN1, CLCNKA, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, PTGS2, UGT1A9	Launched
nimodipine	calcium channel blocker	CFTR, NR3C2	Launched
nintedanib	FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB	Launched
NNC-711	GABA uptake inhibitor	SIGMAR1, SLC6A1	Preclinical
nortriptyline	tricyclic antidepressant	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, KCNJ10, PGRMC1, SIGMAR1, SLC6A2, SLC6A4	Launched
noscapine	bradykinin receptor antagonist, tubulin polymerization inhibitor	SIGMAR1	Launched
NPC-15199	ICAM1 antagonist	PPARG	Phase 2
NSC-405020	matrix metalloprotease inhibitor	MMP1	Preclinical
NSC-625987	CDK inhibitor	CDK2, CDK4	Preclinical
nTZDpa	PPAR receptor agonist	PPARG	Preclinical
NU-2058	cyclin D inhibitor	CCNA2, CDK2	Preclinical
NU-6027	CDK inhibitor	CCNA2, CDK2	Preclinical
NVP-AEW541	IGF-1 inhibitor	IGF1R, INSR	Preclinical
NVP-BGJ398	FGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, KDR	Phase 3
NVP-TAE684	ALK tyrosine kinase receptor inhibitor	ALK, INSR	Preclinical
ochromycinone	STAT inhibitor	STAT3	Phase 1
olomoucine	CDK inhibitor	CDK1, CDK2, CDK5, MAPK1	Preclinical
olopatadine	histamine receptor antagonist	HRH1, S100A1, S100A12, S100A13, S100A2, S100B	Launched
orlistat	lipase inhibitor	CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP	Launched
oxfenicine	carnitine palmitoyltransferase inhibitor	CPT1A, CPT1B	Phase 1
pazopanib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1R, FGF1, FGFR1, FGFR3, FLT1, FLT4, ITK, KDR, KIT, PDGFRA, PDGFRB, SH2B3	Launched
PD-166793	collagenase inhibitor, metalloproteinase inhibitor	MMP13, MMP2, MMP3	Preclinical
PD-173074	FGFR inhibitor, VEGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB	Preclinical
perhexiline	carnitine palmitoyltransferase inhibitor	CPT1A	Launched
PF-573228	focal adhesion kinase inhibitor	CDK1, CDK2, CDK7, GSK3B, IKBKB	Preclinical
PHA-793887	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CDK7, CDK9	Phase 1
PHA-848125	CDK inhibitor, growth factor receptor inhibitor	CDK2, CDK4, CDK7, NTRK1	Phase 2
phenolphthalein	indicator dye	UGT1A9	Withdrawn
pifithrin-mu	HSP inhibitor	HSPA1A, TP53	Preclinical
pioglitazone	insulin sensitizer, PPAR receptor agonist	PPARG, TRPM3	Launched
PNU-74654	beta-catenin inhibitor	CTNNB1, TCF4	Preclinical
ponatinib	Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor	ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK	Launched
PRE-084	sigma receptor agonist	SIGMAR1	Preclinical
prednicarbate	phospholipase activator	PLA2G1B	Launched
purvalanol-A	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CSNK1G3, RPS6KA1, SRC	Preclinical
purvalanol-B	tyrosine kinase inhibitor	CDK2, CDK4, CDK5, MAPK1, MAPK3, SRPK2	Preclinical
pyrithione-zinc	ATP synthase inhibitor	KCNQ1, KCNQ2, KCNQ4, KCNQ5	Launched
RBC8	Ral GTPase inhibitor	RALA, RALB	Preclinical
remoxipride	dopamine receptor antagonist	DRD2, DRD3, DRD4, HTR2A, SIGMAR1	Withdrawn
resorcinol	phosphodiesterase inhibitor	CA12, CA14, CA2, PTGS1	Launched
RGB-286638	CDK inhibitor	CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK9, FLT3, GSK3B, JAK2, MAP3K7, MAPK9	Phase 1
rimcazole	sigma receptor antagonist	SIGMAR1	Phase 1
roscovitine	CDK inhibitor	CDK2, CDK9	Phase 2
rosiglitazone	insulin sensitizer, PPAR receptor agonist	FFAR1, PPARG, TRPC5, TRPM3	Withdrawn
RS-504393	CC chemokine receptor antagonist	CCL2, CCR2	Preclinical
RX-3117	CDK inhibitor, DNA synthesis inhibitor	CDK2, DNMT1	Phase 1/Phase 2
ryuvidine	histone lysine methyltransferase inhibitor	CDK2, CDK4	Preclinical
R547	CDK inhibitor	CDK1, CDK2, CDK4, CDK7	Phase 1
saccharin	DNA polymerase inhibitor	CA1, CA12, CA2, CA9	Launched
salicylic-acid	cyclooxygenase inhibitor, prostanoid receptor antagonist	AKR1C1, ASIC3, PTGS1, PTGS2	Launched
saroglitazar	PPAR receptor agonist	PPARA, PPARG	Launched
SB-216763	glycogen synthase kinase inhibitor	CCNA2, CDK2, GSK3A, GSK3B	Preclinical
SCH-900776	CHK inhibitor	CDK2, CHEK1	Phase 2
scopolamine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SI	Launched
SD-2590	matrix metalloprotease inhibitor	MMP1, MMP13, MMP2	Preclinical
SirReal-2	SIRT inhibitor	SIRT2	Preclinical
sirtinol	SIRT inhibitor	SIRT1, SIRT2	Preclinical
sivelestat	elastase inhibitor	CELA1, ELANE	Launched
SK&F-10047-(+)	sigma receptor agonist	SIGMAR1	Phase 1
SM-21	sigma receptor antagonist	PGRMC1	Preclinical
splitomycin	SIRT inhibitor	SIRT1	Preclinical
SR-1664	PPAR receptor ligand	PPARG	Preclinical
SRT1720	SIRT activator	SIRT1	Preclinical
SRT2104	SIRT activator	SIRT1	Phase 2
STAT3-inhibitor-VI	STAT inhibitor	STAT3	Preclinical
sucrose		ACTA1, ATOX1, C22orf28, LYZ	Launched
sulfasalazine	cyclooxygenase inhibitor	ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, PTGS1, PTGS2, SLC46A1, SLC7A11, TBXAS1	Launched
suramin	DNA synthesis inhibitor	F2, FSHR, P2RY1, P2RY11, P2RY13, P2RY2, PLA2G2A, RYR1, RYR2, SIRT5	Launched
SU9516	CDK inhibitor	CDK1, CDK2, CDK4, CDK5	Preclinical
S26948	PPAR receptor agonist	PPARG	Preclinical
S4	carbonic anhydrase inhibitor	CA12, CA9	Preclinical
T-0070907	PPAR receptor antagonist	PPARG	Preclinical
taurocholate	G protein-coupled receptor agonist	CEL, FABP6, SLCO1C1	Phase 1
telmisartan	angiotensin receptor antagonist	AGTR1, PPARG	Launched
tenovin-1	SIRT inhibitor, TP53 activator	SIRT1	Preclinical
tenovin-6	SIRT inhibitor	SIRT1, SIRT2, SIRT3	Preclinical
tesaglitazar	insulin sensitizer, PPAR receptor agonist	PPARA, PPARG	Phase 3
TG-02	CDK inhibitor, FLT3 inhibitor, JAK inhibitor	CDK1, CDK2, CDK7, CDK9, FLT3, JAK2	Phase 1/Phase 2
tiplaxtinin	plasminogen activator inhibitor	SERPINE1	Phase 1
topiramate	carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist	CA1, CA12, CA2, CA4, CA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
troglitazone	insulin sensitizer, PPAR receptor agonist	CYP2C8, PPARG, TRPM3	Withdrawn
U-104	carbonic anhydrase inhibitor	CA1, CA12, CA2, CA9	Phase 1/Phase 2
UK-356618	metalloproteinase inhibitor	MMP13, MMP14, MMP2, MMP3, MMP9	Preclinical
urea	hydroxy radical formation stimulant	ARG1, CA2, CTNNB1	Launched
ursolic-acid	ATPase inhibitor, NFkB pathway inhibitor, STAT inhibitor	HSD11B1, PLA2G1B, PTPN1, PYGM	Phase 2/Phase 3
valdecoxib	cyclooxygenase inhibitor	CA12, PTGS2	Withdrawn
vandetanib	EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA	Launched
VER-155008	HSP inhibitor	HSPA1A	Preclinical
WAY-170523	metalloproteinase inhibitor	MMP13	Preclinical
WAY-200070	estrogen receptor agonist	ERBB2, ERBB3, ERBB4, ESR2	Preclinical
WP1066	STAT inhibitor	STAT3	Phase 1
yohimbine	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8	Launched
Y16	rho associated kinase inhibitor	RHOA	Preclinical
2-aminobenzenesulfonamide	carbonic anhydrase inhibitor	CA12, CA14, CA2, CA6, CA9	Preclinical
3-bromopyruvate	hexokinase inhibitor	HK2	Preclinical
4-IBP	sigma receptor agonist	SIGMAR1	Preclinical
4-PPBP	sigma receptor ligand	SIGMAR1	Preclinical
